Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer’s disease via activation of adenosine A1 receptor
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 730, 135016
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 32 references indexed in Scilit:
- Coadministration of cannabinoid CB1-receptor and adenosine A1-receptor antagonists improves the acquisition of spatial memory in miceBehavioural Pharmacology, 2012
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque FormationThe Journal of Neuroscience, 2006
- Kinetic distribution of paeoniflorin in cortex of normal and cerebral ischemia‐reperfusion rats after intravenous administration of Paeoniae Radix extractBiomedical Chromatography, 2006
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- T-maze alternation in the rodentNature Protocols, 2006
- Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1receptorBritish Journal of Pharmacology, 2006
- Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonistsBritish Journal of Pharmacology, 2005
- A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple SclerosisJournal of Neuroscience, 2004
- 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): A Useful Tool for Pharmacologists and Physiologists?General Pharmacology: The Vascular System, 1994